Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Gimv NV is a leading European investment company specializing in private equity and venture capital. Founded in 1980 and headquartered in Antwerp, Belgium, it partners with entrepreneurial and innovative companies exhibiting high-growth potential to build sector leaders through sustainable value creation. Gimv operates across five forward-looking investment platforms: Connected Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities, addressing key societal challenges like digitalization, healthcare innovation, energy transition, and sustainable living. With a portfolio of approximately 61 companies valued at around 1.6 billion euros, these holdings generate combined turnover of 4.5 billion euros and employ over 20,000 professionals. Gimv employs a flexible investment approach, utilizing its solid balance sheet for direct equity investments ranging from 5 to 150 million euros, primarily in Benelux, France, and DACH regions. As an active, long-term shareholder, it emphasizes ESG integration, operational excellence, and growth strategies such as internationalization and buy-and-build, supported by specialized teams with deep sector expertise.
€44.80
+€0.35 (+0.79%)
EOD Jun 23, 2026 · Twelve Data
Revenue grew 11.5%, still solid.
Negative free cash flow of -€51M. The business is consuming cash, not generating it.
6.0x earnings. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€338M
▲ +11.5% YoY
Net Income (TTM)
€219M
▲ +0.9% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
-€51M
▼ -13.3% YoY
Op. Cash Flow (TTM)
-€51M
▼ -13.3% YoY
Net Debt
-€177M
Net Cash Position
Cash & Equiv.
€538M
3Y CAGR: +8.6%
Continue Research
At a P/E of 6.0, Gimv NV (GIMB.XBRU)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in .
On quality, Gimv NV scores 31/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 2.8%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Gimv NV scores 31 out of 100 on Intrinsiqq's quality score, passing 2 of 5 checks, which makes it a lower-quality business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
Yes, Gimv NV pays a regular dividend of about €1.26 per share per year (typically in quarterly installments), a yield of roughly 2.8% at the current price. That is a payout ratio of about 16.8% of earnings, so the dividend is amply covered by earnings. Gimv NV has grown the dividend at roughly 1.1% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For GIMB.XBRU's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. you should weigh GIMB.XBRU's valuation and scores 31/100 on quality (lower-quality). It also yields about 2.8%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.